Article
Publicly Available
Frontmatter
Published/Copyright:
September 2, 2017
Published Online: 2017-9-2
Published in Print: 2017-9-26
©2017 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Reviews
- Aeromonas sobria serine protease (ASP): a subtilisin family endopeptidase with multiple virulence activities
- Targeting and inactivation of bacterial toxins by human defensins
- S100A6 – focus on recent developments
- Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach
- Research Articles/Short Communications
- Protein Structure and Function
- I36T↑T mutation in South African subtype C (C-SA) HIV-1 protease significantly alters protease-drug interactions
- Cell Biology and Signaling
- Mutation of N-linked glycosylation in EpCAM affected cell adhesion in breast cancer cells
- Galanin suppresses proliferation of human U251 and T98G glioma cells via its subtype 1 receptor
- Role of sigma 1 receptor in high fat diet-induced peripheral neuropathy
- Proteolysis
- Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer
Articles in the same Issue
- Frontmatter
- Reviews
- Aeromonas sobria serine protease (ASP): a subtilisin family endopeptidase with multiple virulence activities
- Targeting and inactivation of bacterial toxins by human defensins
- S100A6 – focus on recent developments
- Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach
- Research Articles/Short Communications
- Protein Structure and Function
- I36T↑T mutation in South African subtype C (C-SA) HIV-1 protease significantly alters protease-drug interactions
- Cell Biology and Signaling
- Mutation of N-linked glycosylation in EpCAM affected cell adhesion in breast cancer cells
- Galanin suppresses proliferation of human U251 and T98G glioma cells via its subtype 1 receptor
- Role of sigma 1 receptor in high fat diet-induced peripheral neuropathy
- Proteolysis
- Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer